/Investor DB

Phase Two Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Exthymic Corporationexthymic.cominApr 2024

Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.

BiotechHealthtechSan Diego, US

Rich Stoner(Founder)inDan Knudsen(Founder)Kevin Cooksy(Founder)in

Co-investorsHAWKTAILKdT Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.